MKC3946
CAS No. 1093119-54-0
MKC3946( —— )
Catalog No. M23297 CAS No. 1093119-54-0
MKC3946 is an effective and soluble IRE1α inhibitor which triggered modest growth inhibition in multiple myeloma cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 156 | In Stock |
|
| 10MG | 251 | In Stock |
|
| 25MG | 421 | In Stock |
|
| 50MG | 619 | In Stock |
|
| 100MG | 880 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMKC3946
-
NoteResearch use only, not for human use.
-
Brief DescriptionMKC3946 is an effective and soluble IRE1α inhibitor which triggered modest growth inhibition in multiple myeloma cell lines.
-
DescriptionMKC3946 is an effective and soluble IRE1α inhibitor which triggered modest growth inhibition in multiple myeloma cell lines.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIRE1α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1093119-54-0
-
Formula Weight380.46
-
Molecular FormulaC21H20N2O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:30 mg/mL (78.85 mM)
-
SMILESCN1CCN(CC1)C(=O)C2=CC=C(S2)C3=CC4=C(C=C3)C(=C(C=C4)O)C=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sun H, et al. Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia. Oncotarget. 2016 Apr 5;7(14):18736-49.
molnova catalog
related products
-
Galactinol Hydrate
Galactinol Hydrate belongs to the class of organic compounds known as O-glycosyl compounds.?
-
Tangshenoside I
Tangshenoside I might be a potential bioactive marker related to the hematopoietic and immunologic functions of Codonopsis Radix, which could be recommended as the index compound. It has α-glucosidase inhibition activity.
-
Angelol M
Angelol M shows activity in inhibiting prostate specific antigen (PSA) secreted from androgen dependent prostate cancer cell line, LNCaP cells.
Cart
sales@molnova.com